How many institutions held AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in Q2 2022?

41 institutional investors reported AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

Q: What does CUSIP 005111109 represent in this 13F holders report?

CUSIP 005111109 is the security identifier for AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 005111109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 60,359,615
Total 13F shares: 11,180,047
Share change: -4,411,104
Total reported value: $12,516,000
Put/Call ratio: 82%
Price per share: $1.12
Number of holders: 41
Value change: -$5,242,416
Number of buys: 19
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 005111109?
CUSIP 005111109 identifies AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 005111109:

Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Top shareholders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	4.4%	2,648,386	$3,681,000	—	31 Mar 2022	13F
ORBIMED ADVISORS LLC	13F 3/4/5	Company · Director, 10%+ Owner	4.4%	2,648,386	$3,681,000	—	31 Mar 2022	13F 3/4/5
Shahzad Malik	3/4/5	Director	— mixed-class rows	1,562,757 mixed-class rows	$2,426,946	—	17 Jun 2021	3/4/5
Capital World Investors	13F	Company	2.7%	1,600,000	$2,224,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.1%	1,243,660	$1,729,000	—	31 Mar 2022	13F
SABBY MANAGEMENT, LLC	13F	Company	1.7%	1,018,950	$1,416,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	1.2%	751,934	$1,045,000	—	31 Mar 2022	13F
Kamunting Street Capital Management, L.P.	13F	Company	1.1%	691,371	$961,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	1.1%	686,617	$954,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.87%	525,753	$731,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.8%	481,303	$669,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.71%	430,865	$599,000	—	31 Mar 2022	13F
Granite Point Capital Management, L.P.	13F	Company	0.6%	359,333	$499,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.59%	358,700	$499,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.54%	328,101	$456,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.52%	316,477	$440,000	—	31 Mar 2022	13F
AMERICAN FINANCIAL GROUP INC	13F	Company	0.5%	299,995	$417,000	—	31 Mar 2022	13F
HighTower Advisors, LLC	13F	Company	0.4%	240,998	$335,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.33%	198,759	$276,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.28%	167,700	$233,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.27%	162,135	$226,000	—	31 Mar 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.17%	100,000	$139,000	—	31 Mar 2022	13F
James F. Hinrichs.	3/4/5	Director	— mixed-class rows	95,910 mixed-class rows	$119,043	—	16 Jun 2022	3/4/5
Vincent J. Burgess	3/4/5	Chief Executive Officer, Director	— class O/S missing	61,469	$95,892	—	01 Apr 2022	3/4/5
Nuveen Asset Management, LLC	13F	Company	0.08%	49,162	$94,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	64,077	$89,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.1%	59,978	$83,000	—	31 Mar 2022	13F
Steven McQuillan	3/4/5	SVP, Clinical Affairs & QA	— class O/S missing	45,844	$71,517	—	01 Apr 2022	3/4/5
SIMPLEX TRADING, LLC	13F	Company	0.09%	51,607	$71,000	—	31 Mar 2022	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.08%	49,941	$69,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	44,012	$61,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.07%	43,455	$61,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.07%	39,813	$56,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.06%	38,737	$54,000	—	31 Mar 2022	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.06%	37,401	$52,000	—	31 Mar 2022	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.06%	34,400	$48,000	—	31 Mar 2022	13F
BANK OF MONTREAL /CAN/	13F	Company	0.03%	17,270	$34,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.03%	18,469	$26,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	15,828	$22,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.03%	15,774	$22,000	—	31 Mar 2022	13F
Westside Investment Management, Inc.	13F	Company	0.02%	14,000	$19,000	—	31 Mar 2022	13F
Daniella Cramp	3/4/5	Director	— mixed-class rows	31,223 mixed-class rows	$18,132	—	16 Jun 2022	3/4/5
RHUMBLINE ADVISERS	13F	Company	0.02%	12,238	$17,000	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	0.02%	12,174	$17,000	—	31 Mar 2022	13F
U.S. Capital Wealth Advisors, LLC	13F	Company	0.02%	11,118	$15,000	—	31 Mar 2022	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.02%	10,115	$14,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	10,031	$14,000	—	31 Mar 2022	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.02%	9,491	$13,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	9,200	$13,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	8,965	$12,000	—	31 Mar 2022	13F

Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q2 2022

As of 30 Jun 2022, Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,180,047 shares. The largest 10 holders included ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Capital World Investors, VANGUARD GROUP INC, Kamunting Street Capital Management, L.P., GSA CAPITAL PARTNERS LLP, AMERICAN FINANCIAL GROUP INC, RENAISSANCE TECHNOLOGIES LLC, HighTower Advisors, LLC, and BlackRock Inc.. This page lists 41 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-18

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.